Franklin Biotechnology Discovery Fund C (FBTDX)
149.06
+4.56
(+3.16%)
USD |
Feb 06 2026
FBTDX Asset Allocations & Exposures
Asset Allocation
As of December 31, 2025.
| Type | % Net |
|---|---|
| Cash | -0.01% |
| Stock | 97.59% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.77% |
| Other | 1.66% |
Market Capitalization
As of December 31, 2025
| Large | 33.01% |
| Mid | 14.43% |
| Small | 52.56% |
Region Exposure
| Americas | 75.40% |
|---|---|
|
North America
|
75.40% |
| Canada | 0.67% |
| United States | 74.73% |
|
Latin America
|
0.00% |
As of December 31, 2025. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 20.19% |
|---|---|
| United Kingdom | 3.34% |
|
Europe Developed
|
16.85% |
| Denmark | 3.20% |
| France | 2.82% |
| Germany | 0.26% |
| Ireland | 4.70% |
| Netherlands | 5.30% |
| Sweden | 0.16% |
| Switzerland | 0.42% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.00% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 4.41% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
95.50% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
95.50% |
| Utilities |
|
0.00% |
| Not Classified |
|
4.50% |
| Non Classified Equity |
|
2.75% |
| Not Classified - Non Equity |
|
1.75% |
As of December 31, 2025
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |